The global Dengue ELISA Kits market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Dengue ELISA Kits are enzyme-linked immunosorbent assay (ELISA) kits specifically designed for the detection of antibodies or antigens related to the Dengue virus in patient samples. Dengue is a mosquito-borne viral infection that can cause a range of symptoms from mild flu-like illness to severe dengue hemorrhagic fever, which can be life-threatening. These ELISA kits help healthcare professionals diagnose Dengue infections by detecting the presence of viral components or antibodies in blood samples, aiding in early detection, management, and monitoring of Dengue cases.

The industry trend for Dengue ELISA Kits is seeing a significant growth due to the increasing global prevalence of Dengue virus infections. As Dengue continues to pose a public health threat in many parts of the world, there is a growing demand for accurate and reliable diagnostic tools like ELISA kits for early detection and surveillance of Dengue outbreaks. Additionally, advancements in technology are leading to the development of more sensitive and specific ELISA kits, further driving the market for Dengue testing products. With ongoing efforts to control Dengue transmission and improve disease management, the demand for Dengue ELISA kits is expected to continue to rise in the industry.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Dengue ELISA Kits market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Dengue ELISA Kits Market Report

Report Metric	Details
Report Name	Dengue ELISA Kits Market
Segment by Type	IgG IgM
Segment by Application	Hospital Laboratory Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	MyBioSource, BosterBio, DEMEDITEC Diagnostics, Abcam, Abbexa, Eagle Bioscience, IBL, Creative Diagnostics, Abnova Corporation, United States Biological, Creative Biolabs, XpressBio, Aviva Systems Biology, Biorbyt, ELK Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Dengue ELISA Kits study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Dengue ELISA Kits Market report?

Ans: The main players in the Dengue ELISA Kits Market are MyBioSource, BosterBio, DEMEDITEC Diagnostics, Abcam, Abbexa, Eagle Bioscience, IBL, Creative Diagnostics, Abnova Corporation, United States Biological, Creative Biolabs, XpressBio, Aviva Systems Biology, Biorbyt, ELK Biotechnology

What are the Application segmentation covered in the Dengue ELISA Kits Market report?

Ans: The Applications covered in the Dengue ELISA Kits Market report are Hospital, Laboratory, Others

What are the Type segmentation covered in the Dengue ELISA Kits Market report?

Ans: The Types covered in the Dengue ELISA Kits Market report are IgG, IgM

1 Study Coverage

1.1 Introduction to Dengue ELISA Kits: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Dengue ELISA Kits Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 IgG

1.2.3 IgM

1.3 Market Segmentation by Application

1.3.1 Global Dengue ELISA Kits Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Laboratory

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Dengue ELISA Kits Revenue Estimates and Forecasts 2020-2031

2.2 Global Dengue ELISA Kits Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Dengue ELISA Kits Sales Estimates and Forecasts 2020-2031

2.4 Global Dengue ELISA Kits Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Dengue ELISA Kits Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Dengue ELISA Kits Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 IgG Market Size by Manufacturers

3.5.2 IgM Market Size by Manufacturers

3.6 Global Dengue ELISA Kits Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Dengue ELISA Kits Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Dengue ELISA Kits Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Dengue ELISA Kits Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Dengue ELISA Kits Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Dengue ELISA Kits Sales and Revenue by Type (2020-2031)

6.4 North America Dengue ELISA Kits Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Dengue ELISA Kits Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Dengue ELISA Kits Sales and Revenue by Type (2020-2031)

7.4 Europe Dengue ELISA Kits Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Dengue ELISA Kits Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Dengue ELISA Kits Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Dengue ELISA Kits Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Dengue ELISA Kits Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Dengue ELISA Kits Sales and Revenue by Type (2020-2031)

9.4 Central and South America Dengue ELISA Kits Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Dengue ELISA Kits Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Dengue ELISA Kits Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Dengue ELISA Kits Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Dengue ELISA Kits Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 MyBioSource

11.1.1 MyBioSource Corporation Information

11.1.2 MyBioSource Business Overview

11.1.3 MyBioSource Dengue ELISA Kits Product Models, Descriptions and Specifications

11.1.4 MyBioSource Dengue ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 MyBioSource Dengue ELISA Kits Sales by Product in 2024

11.1.6 MyBioSource Dengue ELISA Kits Sales by Application in 2024

11.1.7 MyBioSource Dengue ELISA Kits Sales by Geographic Area in 2024

11.1.8 MyBioSource Dengue ELISA Kits SWOT Analysis

11.1.9 MyBioSource Recent Developments

11.2 BosterBio

11.2.1 BosterBio Corporation Information

11.2.2 BosterBio Business Overview

11.2.3 BosterBio Dengue ELISA Kits Product Models, Descriptions and Specifications

11.2.4 BosterBio Dengue ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 BosterBio Dengue ELISA Kits Sales by Product in 2024

11.2.6 BosterBio Dengue ELISA Kits Sales by Application in 2024

11.2.7 BosterBio Dengue ELISA Kits Sales by Geographic Area in 2024

11.2.8 BosterBio Dengue ELISA Kits SWOT Analysis

11.2.9 BosterBio Recent Developments

11.3 DEMEDITEC Diagnostics

11.3.1 DEMEDITEC Diagnostics Corporation Information

11.3.2 DEMEDITEC Diagnostics Business Overview

11.3.3 DEMEDITEC Diagnostics Dengue ELISA Kits Product Models, Descriptions and Specifications

11.3.4 DEMEDITEC Diagnostics Dengue ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 DEMEDITEC Diagnostics Dengue ELISA Kits Sales by Product in 2024

11.3.6 DEMEDITEC Diagnostics Dengue ELISA Kits Sales by Application in 2024

11.3.7 DEMEDITEC Diagnostics Dengue ELISA Kits Sales by Geographic Area in 2024

11.3.8 DEMEDITEC Diagnostics Dengue ELISA Kits SWOT Analysis

11.3.9 DEMEDITEC Diagnostics Recent Developments

11.4 Abcam

11.4.1 Abcam Corporation Information

11.4.2 Abcam Business Overview

11.4.3 Abcam Dengue ELISA Kits Product Models, Descriptions and Specifications

11.4.4 Abcam Dengue ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Abcam Dengue ELISA Kits Sales by Product in 2024

11.4.6 Abcam Dengue ELISA Kits Sales by Application in 2024

11.4.7 Abcam Dengue ELISA Kits Sales by Geographic Area in 2024

11.4.8 Abcam Dengue ELISA Kits SWOT Analysis

11.4.9 Abcam Recent Developments

11.5 Abbexa

11.5.1 Abbexa Corporation Information

11.5.2 Abbexa Business Overview

11.5.3 Abbexa Dengue ELISA Kits Product Models, Descriptions and Specifications

11.5.4 Abbexa Dengue ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Abbexa Dengue ELISA Kits Sales by Product in 2024

11.5.6 Abbexa Dengue ELISA Kits Sales by Application in 2024

11.5.7 Abbexa Dengue ELISA Kits Sales by Geographic Area in 2024

11.5.8 Abbexa Dengue ELISA Kits SWOT Analysis

11.5.9 Abbexa Recent Developments

11.6 Eagle Bioscience

11.6.1 Eagle Bioscience Corporation Information

11.6.2 Eagle Bioscience Business Overview

11.6.3 Eagle Bioscience Dengue ELISA Kits Product Models, Descriptions and Specifications

11.6.4 Eagle Bioscience Dengue ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Eagle Bioscience Recent Developments

11.7 IBL

11.7.1 IBL Corporation Information

11.7.2 IBL Business Overview

11.7.3 IBL Dengue ELISA Kits Product Models, Descriptions and Specifications

11.7.4 IBL Dengue ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 IBL Recent Developments

11.8 Creative Diagnostics

11.8.1 Creative Diagnostics Corporation Information

11.8.2 Creative Diagnostics Business Overview

11.8.3 Creative Diagnostics Dengue ELISA Kits Product Models, Descriptions and Specifications

11.8.4 Creative Diagnostics Dengue ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Creative Diagnostics Recent Developments

11.9 Abnova Corporation

11.9.1 Abnova Corporation Corporation Information

11.9.2 Abnova Corporation Business Overview

11.9.3 Abnova Corporation Dengue ELISA Kits Product Models, Descriptions and Specifications

11.9.4 Abnova Corporation Dengue ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Abnova Corporation Recent Developments

11.10 United States Biological

11.10.1 United States Biological Corporation Information

11.10.2 United States Biological Business Overview

11.10.3 United States Biological Dengue ELISA Kits Product Models, Descriptions and Specifications

11.10.4 United States Biological Dengue ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 United States Biological Recent Developments

11.11 Creative Biolabs

11.11.1 Creative Biolabs Corporation Information

11.11.2 Creative Biolabs Business Overview

11.11.3 Creative Biolabs Dengue ELISA Kits Product Models, Descriptions and Specifications

11.11.4 Creative Biolabs Dengue ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Creative Biolabs Recent Developments

11.12 XpressBio

11.12.1 XpressBio Corporation Information

11.12.2 XpressBio Business Overview

11.12.3 XpressBio Dengue ELISA Kits Product Models, Descriptions and Specifications

11.12.4 XpressBio Dengue ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 XpressBio Recent Developments

11.13 Aviva Systems Biology

11.13.1 Aviva Systems Biology Corporation Information

11.13.2 Aviva Systems Biology Business Overview

11.13.3 Aviva Systems Biology Dengue ELISA Kits Product Models, Descriptions and Specifications

11.13.4 Aviva Systems Biology Dengue ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.13.5 Aviva Systems Biology Recent Developments

11.14 Biorbyt

11.14.1 Biorbyt Corporation Information

11.14.2 Biorbyt Business Overview

11.14.3 Biorbyt Dengue ELISA Kits Product Models, Descriptions and Specifications

11.14.4 Biorbyt Dengue ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.14.5 Biorbyt Recent Developments

11.15 ELK Biotechnology

11.15.1 ELK Biotechnology Corporation Information

11.15.2 ELK Biotechnology Business Overview

11.15.3 ELK Biotechnology Dengue ELISA Kits Product Models, Descriptions and Specifications

11.15.4 ELK Biotechnology Dengue ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.15.5 ELK Biotechnology Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Dengue ELISA Kits Industry Chain

12.2 Dengue ELISA Kits Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Dengue ELISA Kits Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Dengue ELISA Kits Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Dengue ELISA Kits Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Dengue ELISA Kits Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

MyBioSource

BosterBio

Demeditec Diagnostics

United States Biological

Creative-Biolabs

XpressBio

Aviva Systems Biology

Biorbyt

ELK Biotechnology

List of Tables

Table 1. Global Dengue ELISA Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Dengue ELISA Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Dengue ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Dengue ELISA Kits Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Dengue ELISA Kits Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Dengue ELISA Kits Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Dengue ELISA Kits Sales by Region (2020-2025) & (K Units)

Table 8. Global Dengue ELISA Kits Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Dengue ELISA Kits Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Dengue ELISA Kits Sales Share by Manufacturers (2020-2025)

Table 12. Global Dengue ELISA Kits Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Dengue ELISA Kits Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Dengue ELISA Kits by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dengue ELISA Kits as of 2024)

Table 16. Global Dengue ELISA Kits Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Dengue ELISA Kits Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Dengue ELISA Kits Manufacturing Base and Headquarters

Table 19. Global Dengue ELISA Kits Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Dengue ELISA Kits Sales by Type (2020-2025) & (K Units)

Table 23. Global Dengue ELISA Kits Sales by Type (2026-2031) & (K Units)

Table 24. Global Dengue ELISA Kits Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Dengue ELISA Kits Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Dengue ELISA Kits ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Dengue ELISA Kits Sales by Application (2020-2025) & (K Units)

Table 29. Global Dengue ELISA Kits Sales by Application (2026-2031) & (K Units)

Table 30. Dengue ELISA Kits High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Dengue ELISA Kits Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Dengue ELISA Kits Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Dengue ELISA Kits ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Dengue ELISA Kits Growth Accelerators and Market Barriers

Table 37. North America Dengue ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Dengue ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Dengue ELISA Kits Growth Accelerators and Market Barriers

Table 40. Europe Dengue ELISA Kits Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Dengue ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Dengue ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Dengue ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Dengue ELISA Kits Growth Accelerators and Market Barriers

Table 45. Southeast Asia Dengue ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Dengue ELISA Kits Investment Opportunities and Key Challenges

Table 47. Central and South America Dengue ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Dengue ELISA Kits Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Dengue ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. MyBioSource Corporation Information

Table 51. MyBioSource Description and Major Businesses

Table 52. MyBioSource Product Models, Descriptions and Specifications

Table 53. MyBioSource Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. MyBioSource Sales Value Proportion by Product in 2024

Table 55. MyBioSource Sales Value Proportion by Application in 2024

Table 56. MyBioSource Sales Value Proportion by Geographic Area in 2024

Table 57. MyBioSource Dengue ELISA Kits SWOT Analysis

Table 58. MyBioSource Recent Developments

Table 59. BosterBio Corporation Information

Table 60. BosterBio Description and Major Businesses

Table 61. BosterBio Product Models, Descriptions and Specifications

Table 62. BosterBio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. BosterBio Sales Value Proportion by Product in 2024

Table 64. BosterBio Sales Value Proportion by Application in 2024

Table 65. BosterBio Sales Value Proportion by Geographic Area in 2024

Table 66. BosterBio Dengue ELISA Kits SWOT Analysis

Table 67. BosterBio Recent Developments

Table 68. DEMEDITEC Diagnostics Corporation Information

Table 69. DEMEDITEC Diagnostics Description and Major Businesses

Table 70. DEMEDITEC Diagnostics Product Models, Descriptions and Specifications

Table 71. DEMEDITEC Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. DEMEDITEC Diagnostics Sales Value Proportion by Product in 2024

Table 73. DEMEDITEC Diagnostics Sales Value Proportion by Application in 2024

Table 74. DEMEDITEC Diagnostics Sales Value Proportion by Geographic Area in 2024

Table 75. DEMEDITEC Diagnostics Dengue ELISA Kits SWOT Analysis

Table 76. DEMEDITEC Diagnostics Recent Developments

Table 77. Abcam Corporation Information

Table 78. Abcam Description and Major Businesses

Table 79. Abcam Product Models, Descriptions and Specifications

Table 80. Abcam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Abcam Sales Value Proportion by Product in 2024

Table 82. Abcam Sales Value Proportion by Application in 2024

Table 83. Abcam Sales Value Proportion by Geographic Area in 2024

Table 84. Abcam Dengue ELISA Kits SWOT Analysis

Table 85. Abcam Recent Developments

Table 86. Abbexa Corporation Information

Table 87. Abbexa Description and Major Businesses

Table 88. Abbexa Product Models, Descriptions and Specifications

Table 89. Abbexa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Abbexa Sales Value Proportion by Product in 2024

Table 91. Abbexa Sales Value Proportion by Application in 2024

Table 92. Abbexa Sales Value Proportion by Geographic Area in 2024

Table 93. Abbexa Dengue ELISA Kits SWOT Analysis

Table 94. Abbexa Recent Developments

Table 95. Eagle Bioscience Corporation Information

Table 96. Eagle Bioscience Description and Major Businesses

Table 97. Eagle Bioscience Product Models, Descriptions and Specifications

Table 98. Eagle Bioscience Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Eagle Bioscience Recent Developments

Table 100. IBL Corporation Information

Table 101. IBL Description and Major Businesses

Table 102. IBL Product Models, Descriptions and Specifications

Table 103. IBL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. IBL Recent Developments

Table 105. Creative Diagnostics Corporation Information

Table 106. Creative Diagnostics Description and Major Businesses

Table 107. Creative Diagnostics Product Models, Descriptions and Specifications

Table 108. Creative Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Creative Diagnostics Recent Developments

Table 110. Abnova Corporation Corporation Information

Table 111. Abnova Corporation Description and Major Businesses

Table 112. Abnova Corporation Product Models, Descriptions and Specifications

Table 113. Abnova Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Abnova Corporation Recent Developments

Table 115. United States Biological Corporation Information

Table 116. United States Biological Description and Major Businesses

Table 117. United States Biological Product Models, Descriptions and Specifications

Table 118. United States Biological Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. United States Biological Recent Developments

Table 120. Creative Biolabs Corporation Information

Table 121. Creative Biolabs Description and Major Businesses

Table 122. Creative Biolabs Product Models, Descriptions and Specifications

Table 123. Creative Biolabs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. Creative Biolabs Recent Developments

Table 125. XpressBio Corporation Information

Table 126. XpressBio Description and Major Businesses

Table 127. XpressBio Product Models, Descriptions and Specifications

Table 128. XpressBio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 129. XpressBio Recent Developments

Table 130. Aviva Systems Biology Corporation Information

Table 131. Aviva Systems Biology Description and Major Businesses

Table 132. Aviva Systems Biology Product Models, Descriptions and Specifications

Table 133. Aviva Systems Biology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 134. Aviva Systems Biology Recent Developments

Table 135. Biorbyt Corporation Information

Table 136. Biorbyt Description and Major Businesses

Table 137. Biorbyt Product Models, Descriptions and Specifications

Table 138. Biorbyt Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 139. Biorbyt Recent Developments

Table 140. ELK Biotechnology Corporation Information

Table 141. ELK Biotechnology Description and Major Businesses

Table 142. ELK Biotechnology Product Models, Descriptions and Specifications

Table 143. ELK Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 144. ELK Biotechnology Recent Developments

Table 145. Key Raw Materials Distribution

Table 146. Raw Materials Key Suppliers

Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 148. Milestones in Production Technology Evolution

Table 149. Distributors List

Table 150. Market Trends and Market Evolution

Table 151. Market Drivers and Opportunities

Table 152. Market Challenges, Risks, and Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

List of Figures

Figure 1. Dengue ELISA Kits Product Picture

Figure 2. Global Dengue ELISA Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. IgG Product Picture

Figure 4. IgM Product Picture

Figure 5. Global Dengue ELISA Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Hospital

Figure 7. Laboratory

Figure 8. Others

Figure 9. Dengue ELISA Kits Report Years Considered

Figure 10. Global Dengue ELISA Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Dengue ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 12. Global Dengue ELISA Kits Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Dengue ELISA Kits Revenue Market Share by Region (2020-2031)

Figure 14. Global Dengue ELISA Kits Sales (2020-2031) & (K Units)

Figure 15. Global Dengue ELISA Kits Sales (CAGR) by Region (2020-2031) (K Units)

Figure 16. Global Dengue ELISA Kits Sales Market Share by Region (2020-2031)

Figure 17. Top 5 and Top 10 Manufacturers Dengue ELISA Kits Sales Volume Market Share in 2024

Figure 18. Global Dengue ELISA Kits Revenue Market Share Ranking (2024)

Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 20. IgG Revenue Market Share by Manufacturer in 2024

Figure 21. IgM Revenue Market Share by Manufacturer in 2024

Figure 22. Global Dengue ELISA Kits Sales Market Share by Type (2020-2031)

Figure 23. Global Dengue ELISA Kits Revenue Market Share by Type (2020-2031)

Figure 24. Global Dengue ELISA Kits Sales Market Share by Application (2020-2031)

Figure 25. Global Dengue ELISA Kits Revenue Market Share by Application (2020-2031)

Figure 26. North America Dengue ELISA Kits Sales YoY (2020-2031) & (K Units)

Figure 27. North America Dengue ELISA Kits Revenue YoY (2020-2031) & (US$ Million)

Figure 28. North America Top 5 Manufacturers Dengue ELISA Kits Sales Revenue (US$ Million) in 2024

Figure 29. North America Dengue ELISA Kits Sales Volume (K Units) by Type (2020- 2031)

Figure 30. North America Dengue ELISA Kits Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 31. North America Dengue ELISA Kits Sales Volume (K Units) by Application (2020-2031)

Figure 32. North America Dengue ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)

Figure 33. US Dengue ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 34. Canada Dengue ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 35. Mexico Dengue ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 36. Europe Dengue ELISA Kits Sales YoY (2020-2031) & (K Units)

Figure 37. Europe Dengue ELISA Kits Revenue YoY (2020-2031) & (US$ Million)

Figure 38. Europe Top 5 Manufacturers Dengue ELISA Kits Sales Revenue (US$ Million) in 2024

Figure 39. Europe Dengue ELISA Kits Sales Volume (K Units) by Type (2020-2031)

Figure 40. Europe Dengue ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)

Figure 41. Europe Dengue ELISA Kits Sales Volume (K Units) by Application (2020-2031)

Figure 42. Europe Dengue ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)

Figure 43. Germany Dengue ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 44. France Dengue ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 45. U.K. Dengue ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 46. Italy Dengue ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 47. Russia Dengue ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 48. Asia-Pacific Dengue ELISA Kits Sales YoY (2020-2031) & (K Units)

Figure 49. Asia-Pacific Dengue ELISA Kits Revenue YoY (2020-2031) & (US$ Million)

Figure 50. Asia-Pacific Top 8 Manufacturers Dengue ELISA Kits Sales Revenue (US$ Million) in 2024

Figure 51. Asia-Pacific Dengue ELISA Kits Sales Volume (K Units) by Type (2020- 2031)

Figure 52. Asia-Pacific Dengue ELISA Kits Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 53. Asia-Pacific Dengue ELISA Kits Sales Volume (K Units) by Application (2020-2031)

Figure 54. Asia-Pacific Dengue ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)

Figure 55. Indonesia Dengue ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 56. Japan Dengue ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 57. South Korea Dengue ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 58. China Taiwan Dengue ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 59. India Dengue ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 60. Central and South America Dengue ELISA Kits Sales YoY (2020-2031) & (K Units)

Figure 61. Central and South America Dengue ELISA Kits Revenue YoY (2020-2031) & (US$ Million)

Figure 62. Central and South America Top 5 Manufacturers Dengue ELISA Kits Sales Revenue (US$ Million) in 2024

Figure 63. Central and South America Dengue ELISA Kits Sales Volume (K Units) by Type (2021-2031)

Figure 64. Central and South America Dengue ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)

Figure 65. Central and South America Dengue ELISA Kits Sales Volume (K Units) by Application (2020-2031)

Figure 66. Central and South America Dengue ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)

Figure 67. Brazil Dengue ELISA Kits Revenue (2020-2025) & (US$ Million)

Figure 68. Argentina Dengue ELISA Kits Revenue (2020-2025) & (US$ Million)

Figure 69. Middle East, and Africa Dengue ELISA Kits Sales YoY (2020-2031) & (K Units)

Figure 70. Middle East and Africa Dengue ELISA Kits Revenue YoY (2020-2031) & (US$ Million)

Figure 71. Middle East and Africa Top 5 Manufacturers Dengue ELISA Kits Sales Revenue (US$ Million) in 2024

Figure 72. Middle East and Africa Dengue ELISA Kits Sales Volume (K Units) by Type (2021-2031)

Figure 73. South America Dengue ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)

Figure 74. Middle East and Africa Dengue ELISA Kits Sales Volume (K Units) by Application (2020-2031)

Figure 75. Middle East and Africa Dengue ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)

Figure 76. GCC Countries Dengue ELISA Kits Revenue (2020-2025) & (US$ Million)

Figure 77. Turkey Dengue ELISA Kits Revenue (2020-2025) & (US$ Million)

Figure 78. Egypt Dengue ELISA Kits Revenue (2020-2025) & (US$ Million)

Figure 79. South Africa Dengue ELISA Kits Revenue (2020-2025) & (US$ Million)

Figure 80. Dengue ELISA Kits Industry Chain Mapping

Figure 81. Regional Dengue ELISA Kits Manufacturing Base Distribution (%)

Figure 82. Global Dengue ELISA Kits Production Market Share by Region (2020-2031)

Figure 83. Dengue ELISA Kits Production Process

Figure 84. Regional Dengue ELISA Kits Production Cost Structure

Figure 85. Channels of Distribution (Direct Vs Distribution)

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4U20267

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Global Anticoccidial Solutions Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-16R16865

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Bacterial Enteric Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-3F17301

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Whooping Cough Vaccination Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-4B20221

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Dengue ELISA Kits Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: November 2025

Report Code: QYRE-Auto-0Q20443

Global Dengue ELISA Kits Market Outlook, In‑Depth Analysis & Forecast to 2031

FEATURED COMPANIES

Dengue ELISA Kits Market

Report Includes:

Scope of Dengue ELISA Kits Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Dengue ELISA Kits Market report?

What are the Application segmentation covered in the Dengue ELISA Kits Market report?

What are the Type segmentation covered in the Dengue ELISA Kits Market report?

FEATURED COMPANIES

RELATED REPORTS